BeOne Medicines (ONC) Research & Development (2015 - 2026)
BeOne Medicines' Research & Development was $612.28 million in Q2 2026, up 16.6% from $524.9 million a year earlier and up 13.1% from the prior quarter.
Powered by 
Analysis
BeOne Medicines (ONC) Research & Development (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, BeOne Medicines' Research & Development was $2.29 billion through Jun 30, 2026, up 12.1% year-over-year; for FY2025, it came in at $2.15 billion, up 9.9% from FY2024.
- Research & Development has now increased for 11 consecutive years, with a five-year compound annual growth rate of 10.6% (FY2020 to FY2025).
- In earlier years, Research & Development was $1.95 billion in FY2024 (+9.8%), $1.78 billion in FY2023 (+8.4%), $1.64 billion in FY2022 (+12.4%) and $1.46 billion in FY2021 (+12.7%).
- Quarterly Research & Development has moved between $351.94 million (Q3 2021) and $615.42 million (Q4 2025) over five years.
- Compared with a year earlier, Research & Development has increased for 42 straight quarters, with growth averaging 10.9% over the last eight quarters.
- Across the past five years, year-over-year growth in Research & Development ran from 0.8% in Q3 2021 to 21.6% in Q1 2022.
- Per Business Quant data, ONC's Research & Development in the three quarters before Q2 2026 was $541.22 million (Q1 2026), $615.42 million (Q4 2025) and $523.66 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 2.81 Bn |
| 10 | BeOne Medicines | 41.22 Bn | 22.75 Bn | 1.53 Bn | 612.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 612.28 Mn |
| Mar 31, 2026 | 541.22 Mn |
| Dec 31, 2025 | 615.42 Mn |
| Sep 30, 2025 | 523.66 Mn |
| Jun 30, 2025 | 524.90 Mn |
| Mar 31, 2025 | 481.89 Mn |
| Dec 31, 2024 | 542.01 Mn |
| Sep 30, 2024 | 496.18 Mn |
| Jun 30, 2024 | 454.47 Mn |
| Mar 31, 2024 | 460.64 Mn |
| Dec 31, 2023 | 493.99 Mn |
| Sep 30, 2023 | 453.26 Mn |
| Jun 30, 2023 | 422.76 Mn |
| Mar 31, 2023 | 408.58 Mn |
| Dec 31, 2022 | 446.02 Mn |
| Sep 30, 2022 | 426.36 Mn |
| Jun 30, 2022 | 378.21 Mn |
| Mar 31, 2022 | 389.92 Mn |
| Dec 31, 2021 | 430.49 Mn |
| Sep 30, 2021 | 351.94 Mn |
API Access
BeOne Medicines Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ONC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ONC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ONC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();